AHR American Healthcare REIT, Inc.
Real Estate Investment Trusts · NYSE · SEC CIK 1632970 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $742.15M | $674.25M | $650.77M | $604.08M | $572.94M | $542.50M | $540.60M | $542.74M |
| Cost of revenue | $564.74M | $524.84M | $512.17M | $480.29M | $454.53M | $426.29M | $432.42M | $430.57M |
| SG&A expense | $21.58M | $19.89M | $17.61M | $16.53M | $14.11M | $14.94M | $13.15M | $12.06M |
| Operating income | $164.79M | $137.24M | $125.50M | $111.58M | $105.81M | $103.23M | $94.54M | $99.13M |
| Interest expense | $17.77M | $18.63M | $18.80M | $19.81M | $20.39M | $22.63M | $22.95M | $30.30M |
| Pretax income | $32.26M | $30.98M | $23.49M | $8.53M | $35.55M | $10.81M | -$6.24M | -$31.94M |
| Income tax | $740,000 | -$3,000 | -$525,000 | -$2.42M | -$21.09M | $732,000 | $604,000 | $486,000 |
| Net income | $31.21M | $30.61M | $23.71M | $10.78M | $55.93M | $9.91M | -$6.80M | -$31.77M |
| EBITDA | $255.66M | $209.36M | $192.56M | $166.90M | $155.00M | $145.17M | $135.65M | $146.04M |
| EPS (basic) | 0.14 | 0.16 | 0.13 | — | 0.33 | 0.06 | -0.04 | — |
| EPS (diluted) | 0.14 | 0.16 | 0.13 | — | 0.33 | 0.06 | -0.04 | — |
| Dividends declared per share | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Weighted avg. shares (diluted) | 217.71M | 193.35M | 187.97M | — | 169.80M | 161.14M | 156.92M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $222.77M | $156.90M | $119.38M | $114.84M | $147.36M | $133.49M | $86.06M | $76.70M |
| Inventory | $21.35M | $20.51M | $20.44M | $18.84M | $20.24M | $19.43M | $19.36M | $19.48M |
| Goodwill | $234.94M | $234.94M | $234.94M | $234.94M | $234.94M | $234.94M | $234.94M | $234.94M |
| Intangibles | $370.21M | $237.24M | $250.42M | $253.24M | $181.37M | $155.89M | $156.43M | $161.47M |
| Total assets | $7.61B | $5.70B | $5.60B | $5.43B | $4.77B | $4.51B | $4.46B | $4.49B |
| Total liabilities | $1.96B | $1.96B | $2.08B | $2.07B | $2.05B | $2.04B | $2.16B | $2.18B |
| Shareholders' equity | $5.54B | $3.69B | $3.48B | $3.32B | $2.68B | $2.42B | $2.26B | $2.26B |
| Shares outstanding | 231.48M | 194.69M | 189.94M | 185.91M | — | — | — | — |
| Cash flow statement | ||||||||
| Operating cash flow | $166.89M | $118.62M | $81.07M | $55.16M | $107.19M | $71.47M | $60.62M | $59.51M |
| Investing cash flow | -$1.85B | -$173.34M | -$203.09M | -$709.97M | -$278.46M | -$62.09M | -$32.78M | $87.21M |
| Financing cash flow | $1.75B | $89.46M | $127.20M | $622.20M | $185.69M | $33.12M | -$23.78M | -$139.98M |
| Depreciation & amortization | $90.87M | $72.12M | $67.06M | $55.32M | $49.18M | $41.94M | $41.11M | $46.91M |
| Stock-based compensation | $9.28M | $5.77M | $4.86M | $5.45M | $3.43M | $3.19M | $2.55M | $2.04M |
| Dividends paid | $48.78M | $47.61M | $46.82M | $42.86M | $41.24M | $39.88M | $39.55M | $38.30M |
| Share buybacks | — | — | — | $0 | $0 | $0 | $0 | $0 |
Free plan shows the latest 8 periods; Pro shows all 46 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.